Document is current
Any future updates will be listed below
-
Authors
Pulous, Fadi E. https://orcid.org/0000-0002-0794-8078
Nahrendorf, Matthias https://orcid.org/0000-0002-4021-1887
- License Information
-
More Information
Article History
First Online: 12 January 2022
Competing interests
: M.N. has received funds or material research support from Alnylam, Biotronik, CSL Behring, GlycoMimetics, GSK, Medtronic, Novartis and Pfizer, as well as consulting fees from Biogen, Gimv, IFM Therapeutics, Molecular Imaging, Sigilon and Verseau Therapeutics. F.E.P. declares no competing interests.
